W.L. Gore and Associates announced it has received FDA approval for a thoracic stent graft with a new delivery system used for thoracic endovascular aortic repair procedures.

The stent graft and delivery system (TAG Conformable Thoracic Stent Graft with Active Control System) provides an advanced level of precision and predictable patient outcomes in the endovascular repair of aneurysms, transections and type B dissections of the descending thoracic aorta, the company stated in a press release.